Hero Banner


World-renowned experts will present evidence and advances in the prevention and treatment of cardiometabolic disease with a special focus on inflammation.

The 2023 Spring conference from CMHC will focus on practical approaches to identify and address inflammation as well as how to optimize guideline-directed care for patients with cardiometabolic diseases and risk factors.

Low-grade and chronic systemic inflammation is associated with the development of cardiometabolic diseases, including myocardial infarction, stroke, diabetes, heart failure and more. This two-day conference will feature extensive expert panel discussions and opportunities to interact with colleagues and faculty, so clinicians can walk away with practical advice to apply directly to patient care.

Join and network with over


of your peers, industry KOLs, and exclusive sponsors for an unforgettable event.

Learn the most cutting-edge
practices, information, from the
world’s most renowned experts in medical and aesthetic dermatology.

Expand your skills to improve your practice with actionable insights you can use
immediately upon returning home.


Lifestyle, Diet, Physical Activity, Obesity and Inflammation

Physical Activity and Impact on Chronic Inflammation and Cardiometabolic Health: Exploring the Links & Evidence

Transition of NAFLD to NASH: Inflammation is the Culprit

SPEAKER NAME and Credentials

Cardiovascular Disease

The Impact of Inflammation in Heart Failure: Prevention, Testing, and Treatment

Ileana Piña, MD, MPH

Christie M. Ballantyne, MD

Hypertension & Lipids

Lipoproteins and Inflammation – Focus on LDL, Lp(a) and TG Rich Lipoproteins and New Therapies in Development

Christie M. Ballantyne, Md

Type 2 Diabetes and Kidney Disease

Prevention, Screening and Treatment of Chronic Kidney Disease

Rajiv Agarwal, MD


Immerse yourself in world-class education and then immerse yourself in relaxation in sunny Orlando, Florida!

Bring on the sun! Hit the links, lounge by the pool, or find your favorite way to relax with the vacation-worthy Gaylord Palms Resort & Convention Center.



Here's what our faculty and attendees had to say about our events.

CMHC Faculty Member
Read More
"I would strongly recommend [going to a CMHC event] instead of a paid program because, as a physician, when I'm taking care of a patient, I'm not thinking of a drug. I'm thinking of the patient, who has a certain disease, and I'm thinking about the various options."
Anne HubbleDiabetes Educator in Connecticut
Read More
"This is my favorite conference. I started [attending] in 2013, came to every one through 2019 and I was desperate for it to return [post-pandemic]. When I think back to what we were talking about in 2013, it's like 'Holy Toledo!' look where we've come. It's amazing."
First-time conference attendee
Read More
"I really like this [conference], it's high-energy, it's great to meet all the experts in the field, and it's nice to feel that there are a lot of people who think in this way. [It's] an evolving specialty; we have a lot of metabolic issues with our patients that are managed by different professionals and it's great to know that there is a field that one can be empowered to use the arsenal of medication that is available."
Register Now!

2023 CMHC Spring Registration


Gaylord Palms Resort & Convention Center in Orlando
Rate: $239
Phone: (877) 491-0442
(Mention Cardiometabolic Health Congress to get our group rate)




Here are some common questions we’ll answer NOW, the rest you can ask the experts this May 19-20, 2023, in Orlando!

A: Low-grade systemic inflammation precedes the onset of cardiovascular events by many years, and inflammation is a consistent predictor of cardiovascular risk.

A: A large body of clinical data shows that reducing inflammation has cardiometabolic benefits, and reducing inflammation remains an active area of research that also has important clinical implications, including in the prevention and management of obesity, dyslipidemia, heart failure, chronic kidney disease, hypertension, and type 2 diabetes.

A: An excess of macronutrients in the adipose tissues stimulates inflammatory mediators such as tumor necrosis factor α and interleukin 6; it also reduces the production of adiponectin, promoting inflammation and oxidative stress.

A: Inflammation is a primary mechanism in developed cardiometabolic diseases including coagulation, atherosclerosis, metabolic syndrome, insulin resistance and type 2 diabetes. It is also associated with the development of diseases such as psoriasis, depression, cancer, and renal diseases, conditions that often occur comorbidly in people with cardiometabolic conditions.

A: The activation of nuclear factor kappa B (NF-κB) links pathogenic and cellular danger signals, organizing cellular resistance to perceived threats and triggering inflammation.